A Multi-Center, Randomized, Double-Blind, Placebo Controlled Study of the Efficacy and Safety of Rilonacept for the Prophylaxis of Gout Flares During the Initiation of Allopurinol Therapy.

Trial Profile

A Multi-Center, Randomized, Double-Blind, Placebo Controlled Study of the Efficacy and Safety of Rilonacept for the Prophylaxis of Gout Flares During the Initiation of Allopurinol Therapy.

Completed
Phase of Trial: Phase III

Latest Information Update: 04 May 2017

At a glance

  • Drugs Rilonacept (Primary)
  • Indications Gout
  • Focus Registrational; Therapeutic Use
  • Acronyms PRE-SURGE-1
  • Most Recent Events

    • 09 Jun 2012 Results from a pooled analysis comparing outcomes in patients with and without tophi and/or polyarticular disease presented at the 13th Annual Congress of the European League Against Rheumatism.
    • 09 Jun 2012 Pooled analysis presented at the 13th Annual Congress of the European League Against Rheumatism.
    • 09 Nov 2011 Results of a pooled anlaysis of PRE-SURE I, PRE-SURGE II and RE-SURGE presented at the 75th Annual Scientific Meeting of the American College of Rheumatology and the 46th Annual Meeting of the Association of Rheumatology and Health Professionals.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top